Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Storb

Showing results (101-110 of 315) with videos related to

Pageof 32
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 4, 2019
Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of EculizumabJason P Cooper, Rafic J Farah, Philip A Stevenson, et al.
British Journal of Haematology|January 14, 2010
The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantationZejing Wang, Mohamed L Sorror, Wendy Leisenring, et al.
Blood|October 6, 2007
Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemiaMohamed L Sorror, Barry E Storer, David G Maloney, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2007
Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantationMarco Mielcarek, Barry E Storer, Mary E D Flowers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2009
Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemiaTetsuya Nishida, Michael Hudecek, Ana Kostic, et al.
Leukemia & Lymphoma|July 26, 2016
Allogeneic hematopoietic cell transplant for patients with end stage renal disease requiring dialysis - a single institution experienceMazyar Shadman, Sangeeta Hingorani, Scott A Lanum, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 4, 2005
Effects of race on survival after stem cell transplantationMarco Mielcarek, Theodore Gooley, Paul J Martin, et al.
Blood|July 5, 2005
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCTMohamed L Sorror, Michael B Maris, Rainer Storb, et al.
Transplantation|August 19, 2003
Dog leukocyte antigen nonidentical unrelated canine marrow grafts: enhancement of engraftment by CD4 and CD8 T cellsJens P Panse, Carla Bastianelli, Erlinda B Santos, et al.
Transplantation and Cellular Therapy|March 29, 2021
Addition of Astatine-211-Labeled Anti-CD45 Antibody to TBI as Conditioning for DLA-Identical Marrow Transplantation: A Novel Strategy to Overcome Graft Rejection in a Canine Presensitization Model: "Radioimmunotherapy to Overcome Transfusion-Induced Sensitization"Aya Nakaya, Huiying Qiu, Erlinda B Santos, et al.
Pageof 32

Showing results (101-110 of 315) with videos related to

Sort By:
Pageof 32
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 4, 2019
Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of EculizumabJason P Cooper, Rafic J Farah, Philip A Stevenson, et al.
British Journal of Haematology|January 14, 2010
The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantationZejing Wang, Mohamed L Sorror, Wendy Leisenring, et al.
Blood|October 6, 2007
Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemiaMohamed L Sorror, Barry E Storer, David G Maloney, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2007
Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantationMarco Mielcarek, Barry E Storer, Mary E D Flowers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2009
Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemiaTetsuya Nishida, Michael Hudecek, Ana Kostic, et al.
Leukemia & Lymphoma|July 26, 2016
Allogeneic hematopoietic cell transplant for patients with end stage renal disease requiring dialysis - a single institution experienceMazyar Shadman, Sangeeta Hingorani, Scott A Lanum, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 4, 2005
Effects of race on survival after stem cell transplantationMarco Mielcarek, Theodore Gooley, Paul J Martin, et al.
Blood|July 5, 2005
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCTMohamed L Sorror, Michael B Maris, Rainer Storb, et al.
Transplantation|August 19, 2003
Dog leukocyte antigen nonidentical unrelated canine marrow grafts: enhancement of engraftment by CD4 and CD8 T cellsJens P Panse, Carla Bastianelli, Erlinda B Santos, et al.
Transplantation and Cellular Therapy|March 29, 2021
Addition of Astatine-211-Labeled Anti-CD45 Antibody to TBI as Conditioning for DLA-Identical Marrow Transplantation: A Novel Strategy to Overcome Graft Rejection in a Canine Presensitization Model: "Radioimmunotherapy to Overcome Transfusion-Induced Sensitization"Aya Nakaya, Huiying Qiu, Erlinda B Santos, et al.
Pageof 32